학술논문
A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies.
Document Type
journal article
Author
Wise-Draper, Trisha; Moorthy, Ganesh; Salkeni, Mohamad; Karim, Nagla; Thomas, Hala; Mercer, Carol; Beg, M.; O'Gara, Sue; Olowokure, Olugbenga; Fathallah, Hassana; Kozma, Sara; Thomas, George; Rixe, Olivier; Desai, Pankaj; Morris, John; Wise-Draper, Trisha M; Salkeni, Mohamad A; Karim, Nagla Abdel; Thomas, Hala Elnakat; Mercer, Carol A
Source
Targeted Oncology; Jun2017, Vol. 12 Issue 3, p323-332, 10p
Subject
Language
ISSN
17762596
Abstract
Copyright of Targeted Oncology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)